Tag archive for ‘Teva Pharmaceutical’
Sima Ella On Wednesday, August 26th, 2020

Its Teva Again: A criminal Indictment for Offenses of Coordinating Prices in the U.S

The U.S. Department of Justice filed a criminal indictment against Israeli drugmaker Teva Pharmaceuticals Tuesday in a Pennsylvania federal court. According to the indictment, Teva alleges it engaged in coordinating More...

Jewish Business News On Wednesday, August 19th, 2020

An email reveals: Teva officials allegedly approved “donations” that actually constituted bribe payments

The lawsuits that Teva Pharmaceuticals is exposed to lead to a fall of about 10% in the share price in New York, and to the cancellation of more than   $1 billion from the company’s market value. Today More...

Shai Genish On Wednesday, May 16th, 2018

Buffett doubled his investment in Israeli Drugmaker Teva to 4%

Warren Buffett‘s investment company doubled its investments in Israeli drugmaker Teva in the first quarter of 2018, according to Berkshire’s update on its U.S. stock portfolio with the Securities More...

Jewish Business News On Sunday, July 9th, 2017

Teva ex-Exec gave trade secrets info to her lover, rival company’s CEO

    Apotex, the Canadian pharmaceutical giant, has used sensitive Teva trade secrets transferred to it by the company’s CEO, a former senior Teva executive, according to a lawsuit filed last More...

Shiri Habib-Valdhorn On Tuesday, January 27th, 2015

Teva rivals urge US court to expedite Copaxone suit

Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) who are developing a More...

Globes On Monday, January 26th, 2015

Teva gets first “Sell” recommendation

Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) posted its highest return More...

Globes On Monday, January 12th, 2015

Perrigo good acquisition candidate for Teva – report

Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a suitable acquisition for Teva Pharmaceutical More...

Gil Tanenbaum On Friday, January 9th, 2015

Gamida Cell Has Success With Its Nicord Blood Cancer Medication

Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that the first person has been successfully transplanted with cryopreserved More...

Teva launches generic blood pressure treatment in US

– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in More...

FDA approves Teva allergy spray for children

– The QNASL nasal spray, approved in 2012 for adults, treats nasal symptoms of allergic rhinitis, including hay fever, in children. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) More...

Wordpress site Developed by Fixing WordPress Problems